Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 2,168	$ 4,088
Restricted cash	700
Prepaid expenses and other current assets	371	41
Total current assets	3,239	4,129
Long-term restricted cash	7	10
Total assets	3,246	4,139
Current liabilities:
Accounts payable	529	272
Accrued expenses and other current liabilities	160	57
Total current liabilities	689	329
Total liabilities	689	329
Commitments and contingencies (Note 9)
Stockholders’ equity:
Preferred stock, $0.0001 par value — 500,000 shares authorized; 6,746 shares designated Series A Convertible Preferred Stock: no shares issued and outstanding at June 30, 2026 and December 31, 2025;1,100 shares designated Series B Convertible Preferred Stock: 1,000 shares issued and outstanding at June 30, 2026, and no shares issued and outstanding at December 31, 2025	966
Common stock, $0.0001 par value — 200,000,000 shares authorized; 3,652,285 shares issued and outstanding at June 30, 2026, and December 31, 2025
Additional paid-in capital	306,117	306,128
Accumulated deficit	(304,526)	(302,318)
Total stockholders’ equity	2,557	3,810
Total liabilities and stockholders’ equity	$ 3,246	$ 4,139

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Name:	us-gaap_AccountsPayableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.

+ References

No definition available.